Dr. Yeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
375 Longwood Ave, 4th Floor
Beth Israel Deaconess Medical Center, Baker 4
Boston, MA 02215Phone+1 617-632-7701
Summary
- Dr. Robert W. Yeh is Section Chief of Interventional Cardiology at Beth Israel Deaconess Medical Center, Director of the Richard A. and Susan F. Smith Center for Outcomes Research, and the Katz Silver Family Professor of
Medicine at Harvard Medical School. He is an internationally recognized expert in complex coronary intervention, and in the evaluation of medical devices.
Education & Training
- Harvard Medical SchoolClass of 2003
- University of California (San Francisco)Fellowship, Cardiovascular Disease
- Massachusetts General HospitalResidency, Internal Medicine
- Massachusetts General HospitalFellowship, Interventional Cardiology
- University of OxfordMBA, Business Administration, Distinction
- London School of Hygiene and Tropical Medicine/London School of Economics and Political ScienceMSc, Health Policy, Planning and Financing
Certifications & Licensure
- CA State Medical License 2006 - Present
- MA State Medical License 2005 - 2025
- WA State Medical License 2015 - 2015
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Member American Society for Clinical Investigation, 2024
- Joseph A. Vita Award American Heart Association, 2020
- Fellow (FACC) American College of Cardiology
- Join now to see all
Clinical Trials
- Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study) Start of enrollment: 2020 Jul 01
- A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) Start of enrollment: 2021 May 11
- Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment Start of enrollment: 2023 Jun 21
Publications & Presentations
PubMed
- 1368 citationsTwelve or 30 months of dual antiplatelet therapy after drug-eluting stents.Laura Mauri, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip
The New England Journal of Medicine. 2014-12-03 - 1515 citationsExecutive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, Donna K. Arnett, Michael J. Blaha
Circulation. 2016-01-26 - 161 citationsAssociation of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.Eric A. Secemsky, Harun Kundi, Ido Weinberg, Michael R. Jaff, Anna K. Krawisz
JAMA Cardiology. 2019-04-01
Journal Articles
- Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction with Multivessel Coronary Artery Disea...Eric A Secemsky, Jeptha P Curtis, Salim S Virani, Ehrin J Armstrong, Kendrick A Shunk, Ralph G Brindis, Deepak Bhatt, Robert W Yeh, JAMA Cardiology
- Misclassification of Hospital Performance Under the Hospital Readmissions Reduction ProgramRishi K Wadhera, Robert W Yeh, JAMA Cardiology
- Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in t...Rohan Khera, Eric A Secemsky, Harlan M Krumholz, Kendrick A Shunk, Salim S Virani, Deepak L Bhatt, Jeptha Curtis, Robert W Yeh, JAMA Internal Medicine
- Join now to see all
Authored Content
- Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018August 2020
- Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionMay 2020
Press Mentions
- After DanGer Shock’s Win in AMICS for Impella: What’s Next?April 7th, 2024
- Pacemaker Complication Rate Four Times Higher Than ExpectedMay 23rd, 2023
- Sharp Rise in Cardiovascular Risk Factors Among Young Adults Foreshadows Public Health CrisisMarch 6th, 2023
- Join now to see all
Professional Memberships
- Fellow
- Society for Cardiovascular Angiography and InterventionsFellow
- Fellow
External Links
- PCI for Chronic Total Occlusionhttp://www.bidmc.org/ctocare
- Richard and Susan Smith Center for Outcomes Researchhttp://www.bidmc.org/smithcenter
- Harvard Profilehttps://connects.catalyst.harvard.edu/Profiles/display/Person/30625
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: